To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Burlington-based life sciences giant LabCorp is working ...
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
OncoMethylome Sciences and Laboratory Corporation of America® Holdings (LabCorp®) announced that OncoMethylome has granted LabCorp an exclusive license on certain IP technology to perform commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback